期刊文献+

SELDI-TOF MS技术筛选传染类疾病诊断标志物的研究 被引量:1

Advance in screening of biomarker for diagnosis of infectious diseases using SELDI-TOF MS
原文传递
导出
摘要 表面增强激光解吸电离-飞行时间质谱(SELDI-TOFMS)蛋白质芯片技术是一种基于质谱的高通量分析技术,通常只需要极少的样品就可以进行。目前被广泛应用于传染类疾病的血清和组织蛋白标志物的筛选。蛋白标志物能用于诊断感染、预测疾病状态和病程。精心的实验设计、样品处理和保存,以及选择合理的对照和参数是运用此项技术成功的关键。 Surface enhanced laser desorption ionization-time of flight is a mass spectrometric-based method that requires a minimal amount of sample for analysis and can used for high throughput screening. It has been used to detect serum or tissue protein biomarkers for diagnosis of infectious diseases. The protein biomarkers can be used to diagnose infection,predict disease severity and processes. Exellent experimental design, qualified sample handling and reservation and use of appropriate internal controls are essential to success in use of this technique.
出处 《中国热带医学》 CAS 2010年第6期768-770,共3页 China Tropical Medicine
关键词 表面增强激光解吸电离-飞行时间质谱:传染类疾病 蛋白标志物 早期诊断 Surface enhanced laser desorption ionization-time of flight(SELDI-TOF MS) Infectious diseases Protein biomarkers Early diagnosis
  • 相关文献

参考文献14

  • 1Hutchens TW,Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules[J] . Rapid Communications in Mass Spectrometry, 1993,7: 576-580.
  • 2Poon TC,Hui AY,Chan HL,et al . Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study[J]. Clin. Chem,2005,51: 328-335.
  • 3Schwegler EE, Cazares L, Steel LF, et al. SELDI-TOF MS profiling of serum for detection of the progression of ehronie hepatitis C to hepatoeellular eareinoma[J ]. Hepatology, 2005: 634-642.
  • 4Paradis V,Asselah T,Dargere D,et al. Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin[ J ]. Gastroenterology, 2006,130:2189-2197.
  • 5刘丽杰,王文静,王占峰,陆晔,吴诚,廖萍,朱樑.乙型肝炎病毒相关肝癌血清差异表达蛋白的筛选、鉴定及其诊断价值[J].第二军医大学学报,2008,29(1):6-10. 被引量:8
  • 6Pang RT,Poon TC,Chan KC,et al. Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome [J] . Clin. Chem,2006,52: 421-429.
  • 7王雅杰,张锟,吴小易,郭军华,唐宏,吕虹,黄泽玉,许洋,康熙雄.传染性非典型肺炎患者血清蛋白质指纹图谱分析[J].中华检验医学杂志,2005,28(4):381-383. 被引量:6
  • 8Sun B, Rernpel HG, Pulliam L. Loss of macrophage secreted lysozyme in HIV-1 associated dementia detected by SELDI-TOF massspectrometry[J]. AIDS,2004,18: 1009-1012.
  • 9Papadopoulos MC, Abel PM, Agranoff D, et al. A novel and accurate diagnostic test for human African trypanosomiasis [J] . Lancet, 2004,363: 1358-1363.
  • 10Agranoff D, Fernandez RD,Papadopotdos MC, et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum[J] . Lancet,2006,368:1012-1021 .

二级参考文献18

  • 1WHO. Cumulative Number of Reported Probable Cases of SARS. http://www.who.int/csr/ sars/country/en/country2003_08_15.pdf,2003.
  • 2WHO. Laboratory confirmation of a SARS case in southern China. http://www.who.int/csr/ don/2004_01_05/en/ 2004.
  • 3Petricoin EF, Zoon KC, Kohn EC, et al. Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov, 2002,1:683-695.
  • 4Perz J F,Armstrong G L,Farrington L A,Hutin Y J,Bell B P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide[J]. J Hepatol,2006,45 : 529-538.
  • 5Chang K W,Yang P Y,Lai H Y,Yeh T S,Chen T C,Yeh C T. Identification of a novel actin isoform in hepatocellular carcinoma[J ]. Hepatol Res, 2006,36: 33-39.
  • 6Hoeben A,Landuyt B,Botrus G,De Boeck G,Guetens G,Highly M,et al. Proteomics in cancer research: methods and application of array-based protein profiling technologies[J]. Anal Chim Acta, 2006,564 : 19-33.
  • 7Liotta L A, Ferrari M, Petricoin E. Clinical proteomics: written in blood[J]. Nature,2003,425: 905.
  • 8Liotta L A, Kohn E C. The microenvironment of the tumourhost interface[J]. Nature,2001,411:375-379.
  • 9Petricoin E F, Liotta L A. Proteomic analysis at the bedside: early detection of cancer [J]. Trends Biotechnol, 2002, 20 (12 Suppl) :S30-S34.
  • 10Qu Y, Adam B L, Yasui Y, Ward M D,Cazares L H ,Schellhammer P F,et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients[J]. Clin Chem, 2002,48 : 1835-1843.

共引文献12

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部